
METUPUK member Mary Huckle is featured over 4-pages in the latest ‘Future Dreams‘ magazine: The article immediately afterwards focuses on Laura and Nick, from the Secondary Sisters, and you may

METUPUK member Mary Huckle is featured over 4-pages in the latest ‘Future Dreams‘ magazine: The article immediately afterwards focuses on Laura and Nick, from the Secondary Sisters, and you may

The article starts: They are the women who are dying from secondary breast cancer – but feel ignored by the charities set out to help them. From being labelled the

Over the past couple of weeks, cancer specialist skincare brand Jennifer Young has featured METUPUK and its founder in a couple of blogs. Introduction to MetUpUk ‘Changing the landscape of

METUPUK founder Jo Taylor, and member Madeleine Meynell featured in this piece in Total Health: Jo, along with other patient advocates, have come together to form METUPUK the only patient advocacy group

Further to METUP member Mary Huckle’s appearance on Lorraine yesterday, she was featured in the Daily Mail, which has a daily readership of 2.2 million. Mary Huckle, 54, from London, has metastatic

This morning METUP-UK members appeared on ITV Lorraine, to discuss #BreastCancerAwarenessMonth, talking about the impact of COVID-19 on (secondary) cancer treatment, as Health Secretary Matt Hancock says that cancer treatment

Over the past week, METUP-UK member Bex Lewis has appeared on BBC Radio 5, BBC Radio 4, and BBC Radio Manchester, talking about the real-world impact for those of us

All of us in the metastatic cancer community are deeply sad that Sarah Harding is now dealing with secondary breast cancer, but the language used is problematic: Author Marion Keyes

Over recent years, ringing a bell to signal the ‘end of treatment’ such as chemotherapy or radiation has become common in hospitals and clinics within the UK (having originated in

The coronavirus outbreak has had a serious impact on the treatment of other seriously ill people. Cancer care has been badly affected, with some screening, treatments and trials postponed or